TGFB1 and Hepatic fibrosis: Mangiferin prevented CCl4 and TGF-β1-induced EMT and hepatic fibrosis by reducing HSP27 expression to inhibit the JAK2/STAT3 pathway, which in turn inhibited TGF-β1/Smad pathway activation (94).